We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+12.88%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$3.32B
AUM Growth
+$622M
Cap. Flow
+$387M
Cap. Flow %
11.66%
Top 10 Hldgs %
45.52%
Holding
112
New
12
Increased
30
Reduced
18
Closed
14

Top Buys

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$58.2M
2
DKS icon
Dick's Sporting Goods
DKS
+$48.3M
3
GEHC icon
GE HealthCare
GEHC
+$37.1M
4
DHR icon
Danaher
DHR
+$31.2M
5
GE icon
GE Aerospace
GE
+$24M

Top Sells

Rank Stock Value
1
INSM icon
Insmed
INSM
+$95.9M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$92.5M
3
MSFT icon
Microsoft
MSFT
+$35.3M
4
CMG icon
Chipotle Mexican Grill
CMG
+$27.1M
5
UAL icon
United Airlines
UAL
+$26.2M

Sector Composition

Rank Sector Weight
1 Healthcare 48.97%
2 Technology 9.89%
3 Consumer Discretionary 5.64%
4 Financials 4.91%
5 Communication Services 4.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$432M 13.04%
700,000
+300,000
+75% +$171M
ARQT icon
2
Arcutis Biotherapeutics
ARQT
$3.42B
$162M 4.88%
11,535,582
+112,604
+1% +$1.58M
IWM icon
3
PUT
iShares Russell 2000 ETF
IWM
$80.9B
$152M 4.57%
+702,500
New +$141M
ETNB
4
DELISTED
89bio
ETNB
$140M 4.21%
14,210,000
-125,244
-0.9% -$1.04M
LEGN icon
5
Legend Biotech
LEGN
$4.3B
$134M 4.04%
3,774,009
+24,044
+0.6% +$779K
META icon
6
Meta Platforms (Facebook)
META
$1.51T
$125M 3.78%
169,845
-9,819
-5% -$6.07M
BNTC icon
7
Benitec Biopharma
BNTC
$394M
$116M 3.48%
9,876,506
– –
KO icon
8
Coca-Cola
KO
$354B
$87.3M 2.63%
1,233,230
+817,510
+197% +$58.2M
RARE icon
9
Ultragenyx Pharmaceutical
RARE
$2.65B
$82.8M 2.5%
2,278,000
+253,500
+13% +$9.14M
GE icon
10
GE Aerospace
GE
$367B
$79.9M 2.41%
310,262
+109,600
+55% +$24M
BHVN icon
11
Biohaven
BHVN
$2.16B
$79.3M 2.39%
5,620,271
– –
NVDA icon
12
CALL
NVIDIA
NVDA
$5.01T
$79M 2.38%
+500,000
New +$62.9M
NVDA icon
13
NVIDIA
NVDA
$5.01T
$78.9M 2.38%
499,562
+146,797
+42% +$18.5M
AVBP icon
14
ArriVent BioPharma
AVBP
$1.48B
$74.3M 2.24%
3,412,788
+1,075,292
+46% +$22.3M
TSM icon
15
TSMC
TSM
$2.09T
$68M 2.05%
300,401
-50,113
-14% -$9.28M
IMTX icon
16
Immatics
IMTX
$1.24B
$64.7M 1.95%
12,030,129
+2,895,100
+32% +$14.4M
EYPT icon
17
EyePoint Inc
EYPT
$1.02B
$64M 1.93%
6,804,091
– –
APO icon
18
Apollo Global Management
APO
$70.7B
$60.8M 1.83%
428,460
+31,920
+8% +$4.23M
AMD icon
19
Advanced Micro Devices
AMD
$851B
$56.6M 1.71%
398,799
-5,209
-1% -$567K
AMZN icon
20
Amazon
AMZN
$2.5T
$56.5M 1.7%
257,625
-96,731
-27% -$19.1M
KALV
21
DELISTED
KalVista Pharmaceuticals
KALV
$56M 1.69%
4,955,000
+41,988
+0.9% +$513K
DKS icon
22
Dick's Sporting Goods
DKS
$18.4B
$51.5M 1.55%
+260,465
New +$48.3M
ORCL icon
23
Oracle
ORCL
$331B
$50.4M 1.52%
230,728
+4,410
+2% +$712K
APLS
24
DELISTED
Apellis Pharmaceuticals
APLS
$49.8M 1.5%
2,878,000
+1,231,385
+75% +$22.8M
MSFT icon
25
Microsoft
MSFT
$2.84T
$49.2M 1.48%
98,828
-81,297
-45% -$35.3M
1
2 3 4 5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
AA
Alesco Advisors Pittsford, New York $3.92B AUM 15.21% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return

Suvretta Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Suvretta Capital Management held 112 positions worth $3.32B, up 23% from $2.69B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Suvretta Capital Management deployed $387M of net new capital in Q2 2025, opening 12 new positions and adding to 30 existing holdings. Its largest new stake was Dick's Sporting Goods: 260,465 shares worth $51.5M.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 60% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Insmed, an estimated $95.9M trimmed.

  • Suvretta Capital Management's largest Q2 2025 buy was Dick's Sporting Goods: 260,465 shares worth $51.5M.
  • Suvretta Capital Management added most to Coca-Cola in Q2 2025, an estimated $58.2M increase.
  • Suvretta Capital Management's biggest Q2 2025 reduction was Insmed, cutting an estimated $95.9M.
  • Suvretta Capital Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $92.5M.
  • Suvretta Capital Management's ten largest holdings make up 46% of its $3.32B portfolio in Q2 2025.
  • Suvretta Capital Management opened 12 new positions and closed 14 in Q2 2025.
  • Suvretta Capital Management's portfolio value rose 23% quarter-over-quarter to $3.32B.

Based on Suvretta Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.